54941-44-5

Usage

Uses

Used in Scientific Research:
3-Nitro-4-methylphenylacetic acid is used as a research compound for studying its chemical properties and potential applications in various fields. Its unique structure and reactivity make it a valuable subject for investigation.
Used in Material Preparation:
3-Nitro-4-methylphenylacetic acid is used as a precursor in the synthesis of specific materials or compounds. Its presence in the chemical structure can impart certain properties to the final product, making it a useful component in material science.
Used in Chemical Reactions:
3-Nitro-4-methylphenylacetic acid is used as a reactant in various chemical reactions. Its reactivity with other compounds can lead to the formation of new substances with different properties, which can be further utilized in various applications.

InChI:InChI=1/C9H9NO4/c1-6-2-3-7(5-9(11)12)4-8(6)10(13)14/h2-4H,5H2,1H3,(H,11,12)

Upstream product

• 622-47-9 4-tolylacetic acid 
• 82613-51-2 4-Methyl-3-nitrobenzyl cyanide 
• 74101-68-1 4-bromomethyl-1-methyl-2-nitro-benzene 
• 122-00-9 para-methylacetophenone 
• 19472-75-4 2-nitro-toluene-4-diazonium ; chloride 

Downstream Products

• 96-98-0 4-methyl-3-nitrobenzoic acid 
• 82613-57-8 1-(3'-Amino-4'-methylbenzyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline 
• 82613-53-4 3'-Amino-N-<β-(3,4-dimethoxyphenyl)ethyl>-4'-methyl-phenylacetamide 
• 82613-54-5 1-(4'-Methyl-3'-nitrobenzyl)-6,7-dimethoxy-3,4-dihydroisoquinoline 
• 82613-52-3 N-<β-(3,4-dimethoxyphenyl)-4'-methyl-3'-nitroethyl>phenylacetamide 
• 82613-59-0 1-(3'-Acetamido-4'-methylbenzyl)-2-acetyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline 
• 37777-64-3 3-amino p-tolylacetic acid 
• 54941-46-7 3-Amino-4-methyl-phenylessigsaeure 
• 623154-41-6 C₂₀H₂₃N₅O₃ 
• 623155-47-5 C₁₉H₂₀N₄O₄ 

Relevant academic research and scientific papers

HYBRID NECROPTOSIS INHIBITORS

The present invention relates to heterocyclic compounds (e.g., compounds described by Formula (I)) and pharmaceutically acceptable salts thereof. The invention also features pharmaceutical compositions that include these compounds and their use in therapy for treating conditions in which necroptosis is likely to play a substantial role. The heterocyclic compounds described herein can also achieve improved activity and selectivity towards RIP1 and/or RIP3.

Compounds and methods for modulation of estrogen receptors

Compounds that modulate the estrogen receptor (ER) are disclosed, as well as pharmaceutical compositions containing the same. In a specific embodiment, the compounds are selective for ER-β over ER-α. Methods are disclosed for modulating ER-β in cell and/o

Synthesis of Some 1-(3'-Substituted-4'-methylbenzyl)-2-substituted-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolines

N--4'-methyl-3'-nitrophenylacetamide (4) on cyclisation with POCl3-CH3CN followed by catalytic reduction of the resulting 1-(4'-methyl-3'-nitrobenzyl)-6,7-dimethoxy-3,4-dihydroisoquinoline (6) gives 1-(3'-amino-4'-methylbenzyl)-6,